IL-6/YAP1/β-catenin signaling is involved in intervertebral disc degeneration

J Cell Physiol. 2019 May;234(5):5964-5971. doi: 10.1002/jcp.27065. Epub 2018 Dec 3.

Abstract

Yes-associated protein 1 (YAP1) is a transcriptional coactivator and negative regulator of the Hippo pathway. It regulates diverse cellular processes, such as cell proliferation, contact inhibition, and tissue size. However, the role of YAP1 in intervertebral disc degeneration (IDD) remains elusive. Here, we demonstrated that YAP1 was activated by Interleukin 6 (IL-6) through tyrosine phosphorylation in nucleus pulposus cells (NP cells). Overexpression of YAP1 decreased Sox-9, Col-II, aggrecan expression, whereas increased matrix metalloproteinases 13 level. In contrast, knockdown of YAP1 by small interfering RNA (siRNA) showed opposite effects and rescued IL-6 induced NP cells degeneration. In addition, western blot showed that IL-6 treatment increased YAP1 and β-catenin protein level; co-immunoprecipitation (Co-IP) and immunofluorescence analysis showed that IL-6 enhanced YAP1 and β-catenin interaction and nuclear accumulation. Knockdown of β-catenin by siRNA blocked IL-6 treatment or YAP1 overexpression induced degeneration. Moreover, we found that verteporfin, a specific inhibitor of YAP1, effectively alleviated IDD development in rat disks. Taken together, our findings indicated that YAP1 plays an important role in IDD, and β-catenin is essential for IL-6/YAP1 signaling.

Keywords: intervertebral disc degeneration (IDD); nucleus pulposus (NP); yes-associated protein 1 (YAP1); β-catenin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aggrecans / genetics
  • Aggrecans / metabolism
  • Animals
  • Apoptosis Regulatory Proteins / genetics
  • Apoptosis Regulatory Proteins / metabolism*
  • Cells, Cultured
  • Collagen Type II / genetics
  • Collagen Type II / metabolism
  • Disease Models, Animal
  • Interleukin-6 / pharmacology*
  • Intervertebral Disc Degeneration / drug therapy
  • Intervertebral Disc Degeneration / genetics
  • Intervertebral Disc Degeneration / metabolism*
  • Intervertebral Disc Degeneration / pathology
  • Matrix Metalloproteinase 13 / genetics
  • Matrix Metalloproteinase 13 / metabolism
  • Nucleus Pulposus / drug effects*
  • Nucleus Pulposus / metabolism*
  • Nucleus Pulposus / pathology
  • Phosphorylation
  • Rats, Sprague-Dawley
  • SOX9 Transcription Factor / genetics
  • SOX9 Transcription Factor / metabolism
  • Signal Transduction
  • Tissue Culture Techniques
  • Tyrosine
  • Verteporfin / pharmacology
  • YAP-Signaling Proteins
  • beta Catenin / genetics
  • beta Catenin / metabolism*

Substances

  • Aggrecans
  • Apoptosis Regulatory Proteins
  • Collagen Type II
  • Ctnnb1 protein, rat
  • Interleukin-6
  • SOX9 Transcription Factor
  • Sox9 protein, rat
  • YAP-Signaling Proteins
  • Yap1 protein, rat
  • beta Catenin
  • Verteporfin
  • Tyrosine
  • Matrix Metalloproteinase 13
  • Mmp13 protein, rat